XML 15 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Revenue
Expenses:    
Cost of sales
Research and development 9,005 55,075
Selling, general and administrative 41,400 36,688
Total expenses 50,405 91,763
Loss from operations (50,405) (91,763)
Other income (expense)    
Interest income (expense)
Net loss $ (50,405) $ (91,763)
Net loss per share - basic and diluted (in dollars per share) $ 0 $ 0
Weighted-average number of common shares outstanding - basic and diluted (in shares) 45,572,568 45,572,568